Carotid plaques stabilization and regression with evolocumab

1 September 2025 (09:30 - 09:45)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Tiziana Claudia Aranzulla

Mauriziano Umberto Hospital, Turin (Italy)

5 More presentations in this session

Presentation thumbnail

LipoaScreen – cascade screening for lipoprotein(a)

Associate Professor J. Brinck (Stockholm, SE)

Presentation thumbnail

Triglyceride lowering after MI

Ms J. Schubert (Uppsala, SE)

Presentation thumbnail

NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP

Professor B. Ference (Cambridge, GB)

Presentation thumbnail

Obicetrapib and cardiovascular events

Professor S. Nicholls (Melbourne, AU)

Presentation thumbnail

GAELp(a): National Registry on Lp(a) and Cardiovascular Risk in Argentina

Doctor N. Renna (Mendoza, AR)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: lipids and cardiovascular risk

The Event

Event poster

ESC Congress 2025

1 September 2025 09:30 CET

You may be interested in

Congress Presentation

Primary Results of SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in People with Asymptomatic High-Risk Carotid Stenosis

Congress Presentation

Impact of intensive low-density lipoprotein cholesterol lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome

Congress Presentation

High-intensity lipid-lowering therapy accelerates early plaque regression: a FLOWPROMOTE sub study.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources